Allergy Rhinitis
Sneezing, itchy nose, eyes and roof of mouth, runny or stuffy nose: watery, red, swollen eyes
- Also called Hay fever
Allergic rhinitis pathophysiology
Systemic upper respiratory disease with primarily nasal symptoms
Four phases of allergic rhinitis
Sensitization
initial allergen exposure stimulates beta-lymphocytic IgE (immunoglobin E) production
Early phase
release of preformed mast cell mediators (histamine, proteases) and production of additional mediators (prostaglandins, leukotrienes, etc.)
Cellular Recruitment
circulating leukocytes are attracted to nasal mucosa and release more inflammatory mediators
Late Phase
mucus hypersecretion - begins 2-4 hours after allergen
excess mucus secretion
Allergic rhinitis clinical presentation
Allergic Rhinitis - Exclusions for self care
Allergic Rhinits-Treatment Goals
Allergic Rhinitis - Non-pharmacologic options
avoidance or removal of allergens
- Dust mites: Wash bedding weekly, limit carpets/upholstered furniture/ stuffed animals Cats: Weekly baths
Mold Spores: Lower household humidity, avoid raking
Nasal wetting agents: Saline, propylene, polethylene glycol nasal sprays or gels, neti pot
Non-pharmacologic options: Nasal wetting agent
Non-pharmacologic options: Avoiding or removing allergens
Dust mites: Wash bedding weekly, limit carpets/upholstered furniture/ stuffed animals Cats: Weekly baths
Mold Spores: Lower household humidity, avoid raking
Allergic Rhinitis - Pharmacologic Treatment
Intranasal Corticosteroid Characteristics MOA
MOA: Inhibit multiple cell types and mediators (including histamine) in order to stop the allergic cascade
Intranasal Corticosteroids Drugs
Intranasal Corticosteroid Characteristics Indication
Triamcinolone acetonide adult dosing
Fluticasone Propionate Adult dosing
Budesonide Adult dosing
- 2 sprays in each nostril daily
Triamcinolone acetonide pediatric dosing 6-11 years old
6-11 years old: 1 spray in each nostril daily
- may increase to 2 sprays in each nostril
Fluticasone Propionate pediatric dosing
4-11 years old: 1 spray in each nostril daily
Budesonide Pediatric dosing
6-11 years old- 1 spray in each nostril daily
- 2-5 years old- N/A
Antihistamines MOA
MOA: compete with histamine at central and peripheral H1 receptor sites to prevent histamine-receptor interaction and resulting mediator release